Skip to document

Official Do Not Use List - Joint Commission(1)

Do Not Use List
Course

Fundamentals Of Nursing (NUR121)

28 Documents
Students shared 28 documents in this course
Academic year: 2020/2021
Uploaded by:
Anonymous Student
This document has been uploaded by a student, just like you, who decided to remain anonymous.
County College of Morris

Comments

Please sign in or register to post comments.

Preview text

Facts about the Official “Do Not Use” List

In 2001, The Joint Commission issued a Sentinel Event Alert on the subject of medical abbreviations, and just one year later, its Board of Commissioners approved a National Patient Safety Goal requiring accredited organizations to develop and implement a list of abbreviations not to use. In 2004, The Joint Commission created its “do not use” list of abbreviations (see next page) as part of the requirements for meeting that goal. In 2010, NPSG.02.02 was integrated into the Information Management standards as elements of performance 2 and 3 under IM.02.02.

Currently, this requirement does not apply to preprogrammed health information technology systems (for example, electronic medical records or CPOE systems), but remains under consideration for the future. Organizations contemplating introduction or upgrade of such systems should strive to eliminate the use of dangerous abbreviations, acronyms, symbols, and dose designations from the software.

The National Summit on Medical Abbreviations Participants at the November 2004 National Summit on Medical Abbreviations supported the “do not use” list. Summit conclusions were posted on the Joint Commission Web site for public comment. During the four-week comment period, the Joint Commission received 5,227 responses, including 15,485 comments. More than 80 percent of the respondents supported the creation and adoption of a “do not use” list. However, the field was less supportive of additions to the list. While no additions will be made to the “do not use” list at this time, the following items will be reviewed periodically for possible inclusion:

The symbols “>” and “<” All abbreviations for drug names Apothecary units The symbol “@” The abbreviation “cc” The abbreviation “μg”

This special one-day Summit brought together representatives of more than 70 professional societies and associations and special interest groups to discuss medical errors related to the misuse and misinterpretation of abbreviations, acronyms, and symbols. The objective of the Summit was to reach consensus on the scope and implications of this serious and complex problem and to find reasonable solutions using all of the evidence at hand and in the most dispassionate way possible. The National Summit on Medical Abbreviations was hosted by The Joint Commission with its co-conveners American College of Physicians, American College of Surgeons, American Dental Association, American Hospital Association, American Medical Association, American Society of Health-System Pharmacists, Institute for Safe Medication Practices, and United States Pharmacopeia. Approximately 50 professional societies and associations and selected interest groups participated in the Summit representing every perspective.

For more information Visit jointcommission/PatientSafety/DoNotUseList/, contact the Standards Interpretation Group at (630) 792-5900, or complete the Standards Online Question Submission Form at jointcommission/Standards/OnlineQuestionForm/.

Official “Do Not Use” List 1

Do Not Use Potential Problem Use Instead U (unit) Mistaken for “0” (zero), the number “4” (four) or “cc”

Write "unit"

IU (International Unit) Mistaken for IV (intravenous) or the number 10 (ten)

Write "International Unit"

Q., QD, q., qd (daily) Q.O., QOD, q.o, qod (every other day)

Mistaken for each other Period after the Q mistaken for "I" and the "O" mistaken for "I"

Write "daily" Write "every other day"

Trailing zero (X mg)* Lack of leading zero (.X mg)

Decimal point is missed Write X mg Write 0 mg MS

MSO 4 and MgSO 4

Can mean morphine sulfate or magnesium sulfate Confused for one another

Write "morphine sulfate" Write "magnesium sulfate"

1 Applies to all orders and all medication-related documentation that is handwritten (including free-text computer entry) or on pre-printed forms.

*Exception: A “trailing zero” may be used only where required to demonstrate the level of precision of the value being reported, such as for laboratory results, imaging studies that report size of lesions, or catheter/tube sizes. It may not be used in medication orders or other medication-related documentation.

Additional Abbreviations, Acronyms and Symbols (For possible future inclusion in the Official “Do Not Use” List)

Do Not Use Potential Problem Use Instead > (greater than) < (less than)

Misinterpreted as the number “7” (seven) or the letter “L” Confused for one another

Write “greater than” Write “less than”

Abbreviations for drug names Misinterpreted due to similar abbreviations for multiple drugs

Write drug names in full

Apothecary units Unfamiliar to many practitioners Confused with metric units

Use metric units

@

Mistaken for the number “2” (two)

Write “at”

cc Mistaken for U (units) when poorly written

Write “mL” or "ml" or “milliliters” (“mL” is preferred) μg Mistaken for mg (milligrams) resulting in one thousand-fold overdose

Write "mcg" or “micrograms”

6/

Was this document helpful?

Official Do Not Use List - Joint Commission(1)

Course: Fundamentals Of Nursing (NUR121)

28 Documents
Students shared 28 documents in this course
Was this document helpful?
Facts about the Official “Do Not Use” List
In 2001, The Joint Commission issued a Sentinel Event Alert on the subject of medical abbreviations, and
just one year later, its Board of Commissioners approved a National Patient Safety Goal requiring
accredited organizations to develop and implement a list of abbreviations not to use. In 2004, The Joint
Commission created its “do not use” list of abbreviations (see next page) as part of the requirements for
meeting that goal. In 2010, NPSG.02.02.01 was integrated into the Information Management standards
as elements of performance 2 and 3 under IM.02.02.0.
Currently, this requirement does not apply to preprogrammed health information technology systems (for
example, electronic medical records or CPOE systems), but remains under consideration for the future.
Organizations contemplating introduction or upgrade of such systems should strive to eliminate the use of
dangerous abbreviations, acronyms, symbols, and dose designations from the software.
The National Summit on Medical Abbreviations
Participants at the November 2004 National Summit on Medical Abbreviations supported the “do not use”
list. Summit conclusions were posted on the Joint Commission Web site for public comment. During the
four-week comment period, the Joint Commission received 5,227 responses, including 15,485 comments.
More than 80 percent of the respondents supported the creation and adoption of a “do not use” list.
However, the field was less supportive of additions to the list. While no additions will be made to the “do
not use” list at this time, the following items will be reviewed periodically for possible inclusion:
The symbols “>” and “<”
All abbreviations for drug names
Apothecary units
The symbol “@”
The abbreviation “cc”
The abbreviation “μg”
This special one-day Summit brought together representatives of more than 70 professional societies and
associations and special interest groups to discuss medical errors related to the misuse and
misinterpretation of abbreviations, acronyms, and symbols. The objective of the Summit was to reach
consensus on the scope and implications of this serious and complex problem and to find reasonable
solutions using all of the evidence at hand and in the most dispassionate way possible. The National
Summit on Medical Abbreviations was hosted by The Joint Commission with its co-conveners American
College of Physicians, American College of Surgeons, American Dental Association, American Hospital
Association, American Medical Association, American Society of Health-System Pharmacists, Institute for
Safe Medication Practices, and United States Pharmacopeia. Approximately 50 professional societies
and associations and selected interest groups participated in the Summit representing every perspective.
For more information
Visit http://www.jointcommission.org/PatientSafety/DoNotUseList/, contact the Standards Interpretation
Group at (630) 792-5900, or complete the Standards Online Question Submission Form at
http://www.jointcommission.org/Standards/OnlineQuestionForm/.